BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 280 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2021. The put-call ratio across all filers is 1.68 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $348,000 | +6860.0% | 5,280 | +4881.1% | 0.01% | – |
| Q2 2022 | $5,000 | -97.6% | 106 | -96.8% | 0.00% | -100.0% |
| Q1 2022 | $212,000 | +161.7% | 3,313 | +321.5% | 0.01% | +133.3% |
| Q3 2021 | $81,000 | +72.3% | 786 | +55.3% | 0.00% | -40.0% |
| Q3 2020 | $47,000 | +683.3% | 506 | +612.7% | 0.01% | +400.0% |
| Q2 2020 | $6,000 | -76.0% | 71 | -83.2% | 0.00% | -90.9% |
| Q1 2020 | $25,000 | -75.5% | 423 | -69.4% | 0.01% | -62.1% |
| Q3 2019 | $102,000 | +200.0% | 1,384 | +217.4% | 0.03% | +141.7% |
| Q3 2018 | $34,000 | – | 436 | +43500.0% | 0.01% | – |
| Q4 2017 | $0 | -100.0% | 1 | -99.7% | 0.00% | -100.0% |
| Q3 2017 | $26,000 | -65.3% | 367 | -80.5% | 0.02% | -81.6% |
| Q1 2017 | $75,000 | – | 1,886 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 379,090 | $19,037,900 | 17.25% |
| DAFNA Capital Management LLC | 249,521 | $12,530,945 | 3.90% |
| Rock Springs Capital Management LP | 2,685,294 | $134,855,465 | 3.61% |
| Casdin Capital, LLC | 371,378 | $18,650,603 | 2.06% |
| Novo Holdings A/S | 525,000 | $26,365,500 | 1.95% |
| CHI Advisors LLC | 92,888 | $4,664,835 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 165,890 | $8,330,996 | 1.62% |
| Avidity Partners Management LP | 751,600 | $37,745,352 | 1.52% |
| EMERALD ADVISERS, LLC | 607,037 | $30,485,393 | 1.48% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 464,321 | $23,318,201 | 1.41% |